MKC
59
3
O
37
7
F
54
2
PAYX
65
5
ETR
75
4
CLX
49
3
MO
56
5
L
55
9
UNH
15
12
FSLR
66
-6
BA
53
-3
MDLZ
38
-6
BDX
32
2
LB
71
5
AEE
74
5
AIG
62
2
NOC
34
-6
EA
52
2
AVB
60
6
KMX
53
4
MKC
59
3
O
37
7
F
54
2
PAYX
65
5
ETR
75
4
CLX
49
3
MO
56
5
L
55
9
UNH
15
12
FSLR
66
-6
BA
53
-3
MDLZ
38
-6
BDX
32
2
LB
71
5
AEE
74
5
AIG
62
2
NOC
34
-6
EA
52
2
AVB
60
6
KMX
53
4
Financhill
Back

Charles River Laboratories International Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
48

CRL
Charles River Laboratories International

Last Price:
$141.01
Seasonality Move:
6.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Charles River Laboratories International Stock Forecast

  • Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 11.5% based on the past 24 years of stock performance.
  • Charles River Laboratories International has risen higher in 17 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.83%
  • Is Charles River Laboratories International Stock Undervalued?
    The current Charles River Laboratories International [CRL] share price is $140.97. The Score for CRL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Charles River Laboratories International Stock Go Up Next Year?

  • Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 11.5% based on the past 24 years of stock performance.

Charles River Laboratories International Stock Rating

Sell
48
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International overpriced?

  • Charles River Laboratories International has risen higher in 17 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.83%

Charles River Laboratories International Stock Price History

Is CRL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
criver.com

52-Week Data

52-Week High:
254.15
52-Week Low:
91.86

Prediction Charts

Market Cap:
6.9B
Price in USD:
140.97
Volume:
1.5M
Beta:
0.98

Technical Analysis

SMA50:
138.30
SMA100:
154.63
SMA200:
176.98
52-Wk Change:
-37.28%

Stock Predictions

  • Is Charles River Laboratories International stock public?
    Yes, Charles River Laboratories International is a publicly traded company.
  • What is the Charles River Laboratories International stock quote today?
    The Charles River Laboratories International stock price is 140.97 USD today.
  • How to buy Charles River Laboratories International stock online?
    You can buy Charles River Laboratories International shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 114.71 117.29 117.86 113.94
Apr-30 115.62 118.62 118.69 114.75
May-1 119.38 116.89 120.14 114.24
May-2 120.22 118.46 121.81 118.25
May-5 118.67 119.44 120.89 117.13
May-6 117.44 115.41 120.02 113.89
May-7 141.03 136.97 144.77 131.30
May-8 140.70 141.36 143.86 137.00
May-9 141.21 138.79 143.46 138.46
May-12 145.45 143.08 147.64 139.99
May-13 142.23 144.02 145.64 141.19
May-14 146.00 138.95 146.43 138.78
May-15 138.20 138.89 139.38 135.11
May-16 138.99 140.97 142.60 137.68

Charles River Laboratories International Earnings

Charles River Laboratories International Earnings Report: Per Share Charles River Laboratories International Earnings Q1 Q2 Q3 and Q4 last year and next year.

Charles River Laboratories International Forecast Revenue Growth

Charles River Laboratories International Stock Analysis: Historical quarterly revenues per share for Charles River Laboratories International and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.60 per share, and an increase next year of $0.69 per share.

* Charles River Laboratories International stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.